• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠后综合征在有症状的 COVID-19 患者中的表现:孟加拉国一家三级保健中心的前瞻性队列研究。

Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.

机构信息

Department of Neurology, Dhaka Medical College, Dhaka, Bangladesh.

Department of Medicine, Dhaka Medical College, Dhaka, Bangladesh.

出版信息

PLoS One. 2021 Apr 8;16(4):e0249644. doi: 10.1371/journal.pone.0249644. eCollection 2021.

DOI:10.1371/journal.pone.0249644
PMID:33831043
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8031743/
Abstract

BACKGROUND

Post-coronavirus disease (COVID-19) syndrome includes persistence of symptoms beyond viral clearance and fresh development of symptoms or exaggeration of chronic diseases within a month after initial clinical and virological cure of the disease with a viral etiology. We aimed to determine the incidence, association, and risk factors associated with development of the post-COVID-19 syndrome.

METHODS

We conducted a prospective cohort study at Dhaka Medical College Hospital between June 01, 2020 and August 10, 2020. All the enrolled patients were followed up for a month after clinical improvement, which was defined according the World Health Organization and Bangladesh guidelines as normal body temperature for successive 3 days, significant improvement in respiratory symptoms (respiratory rate <25/breath/minute with no dyspnea), and oxygen saturation >93% without assisted oxygen inhalation.

FINDINGS

Among the 400 recruited patients, 355 patients were analyzed. In total, 46% patients developed post-COVID-19 symptoms, with post-viral fatigue being the most prevalent symptom in 70% cases. The post-COVID-19 syndrome was associated with female gender (relative risk [RR]: 1.2, 95% confidence interval [CI]: 1.02-1.48, p = 0.03), those who required a prolonged time for clinical improvement (p<0.001), and those showing COVID-19 positivity after 14 days (RR: 1.09, 95% CI: 1.00-1.19, p<0.001) of initial positivity. Patients with severe COVID-19 at presentation developed post-COVID-19 syndrome (p = 0.02). Patients with fever (RR: 1.5, 95% CI: 1.05-2.27, p = 0.03), cough (RR: 1.36, 95% CI: 1.02-1.81, p = 0.04), respiratory distress (RR: 1.3, 95% CI: 1.4-1.56, p = 0.001), and lethargy (RR: 1.2, 95% CI: 1.06-1.35, p = 0.003) as the presenting features were associated with the development of the more susceptible to develop post COVID-19 syndrome than the others. Logistic regression analysis revealed female sex, respiratory distress, lethargy, and long duration of the disease as risk factors.

CONCLUSION

Female sex, respiratory distress, lethargy, and long disease duration are critical risk factors for the development of post-COVID-19 syndrome.

摘要

背景

新冠病毒疾病(COVID-19)后综合征包括在病毒清除后持续存在症状,以及在具有病毒病因的疾病初始临床和病毒学治愈后一个月内新出现症状或慢性病加重。我们旨在确定与 COVID-19 后综合征发展相关的发病率、关联和危险因素。

方法

我们在 2020 年 6 月 1 日至 2020 年 8 月 10 日期间在达卡医学院医院进行了一项前瞻性队列研究。所有入组患者在临床改善后随访一个月,这是根据世界卫生组织和孟加拉国指南定义的,连续 3 天体温正常、呼吸症状明显改善(呼吸频率<25/分钟且无呼吸困难)和血氧饱和度>93%,无需辅助吸氧。

结果

在招募的 400 名患者中,对 355 名患者进行了分析。共有 46%的患者出现了 COVID-19 后症状,其中 70%的患者最常见的症状是病毒后疲劳。COVID-19 后综合征与女性性别相关(相对风险 [RR]:1.2,95%置信区间 [CI]:1.02-1.48,p=0.03)、临床改善时间延长(p<0.001)以及初始阳性后 14 天出现 COVID-19 阳性(RR:1.09,95% CI:1.00-1.19,p<0.001)相关。出现 COVID-19 时病情严重的患者出现 COVID-19 后综合征(p=0.02)。发热(RR:1.5,95% CI:1.05-2.27,p=0.03)、咳嗽(RR:1.36,95% CI:1.02-1.81,p=0.04)、呼吸窘迫(RR:1.3,95% CI:1.4-1.56,p=0.001)和乏力(RR:1.2,95% CI:1.06-1.35,p=0.003)是发病时的主要表现,与更易发生 COVID-19 后综合征相关。逻辑回归分析显示,女性、呼吸窘迫、乏力和疾病持续时间长是发生 COVID-19 后综合征的危险因素。

结论

女性、呼吸窘迫、乏力和疾病持续时间长是 COVID-19 后综合征发展的关键危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb47/8031743/bce8b369908f/pone.0249644.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb47/8031743/e08e2cbd9ad3/pone.0249644.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb47/8031743/bce8b369908f/pone.0249644.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb47/8031743/e08e2cbd9ad3/pone.0249644.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb47/8031743/bce8b369908f/pone.0249644.g002.jpg

相似文献

1
Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh.新冠后综合征在有症状的 COVID-19 患者中的表现:孟加拉国一家三级保健中心的前瞻性队列研究。
PLoS One. 2021 Apr 8;16(4):e0249644. doi: 10.1371/journal.pone.0249644. eCollection 2021.
2
Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal.新冠后综合征:尼泊尔一家三甲医院的前瞻性研究。
PLoS One. 2022 Aug 10;17(8):e0272636. doi: 10.1371/journal.pone.0272636. eCollection 2022.
3
Demographic and Clinical Characteristics of Covid-19 Positive Cases: An Exploratory Retrospective Study in a Covid-19 Referral Hospital.Covid-19 阳性病例的人口统计学和临床特征:一家新冠病毒转诊医院的探索性回顾性研究。
Mymensingh Med J. 2024 Oct;33(4):1250-1257.
4
Association of ABO blood groups with presentation and outcomes of confirmed SARS CoV-2 infection: A prospective study in the largest COVID-19 dedicated hospital in Bangladesh.ABO 血型与确诊 SARS-CoV-2 感染的表现和结局的关联:孟加拉国最大 COVID-19 定点医院的前瞻性研究。
PLoS One. 2021 Apr 7;16(4):e0249252. doi: 10.1371/journal.pone.0249252. eCollection 2021.
5
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.德国一家三级保健中心在 SARS-CoV-2 大流行第一波期间住院 COVID-19 患者的临床和病毒学特征:一项前瞻性观察研究。
Infection. 2021 Aug;49(4):703-714. doi: 10.1007/s15010-021-01594-w. Epub 2021 Apr 22.
6
Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.2019 新型冠状病毒感染患者恶化的危险因素:一项荟萃分析。
Int J Med Sci. 2020 Jul 6;17(12):1744-1750. doi: 10.7150/ijms.47052. eCollection 2020.
7
Incidence and risk factors of post COVID-19 syndrome: a Tunisian cohort study.新冠后综合征的发生率及危险因素:一项突尼斯队列研究。
BMC Infect Dis. 2024 May 1;24(1):461. doi: 10.1186/s12879-023-08949-8.
8
Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.鉴定 COVID-19 肺炎院内死亡的风险因素——来自早期爆发的教训。
BMC Infect Dis. 2021 Jan 25;21(1):113. doi: 10.1186/s12879-021-05814-4.
9
Female gender is associated with long COVID syndrome: a prospective cohort study.女性性别与长新冠综合征相关:一项前瞻性队列研究。
Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16. doi: 10.1016/j.cmi.2021.11.002. Epub 2021 Nov 9.
10
Incidence, symptom clusters and determinants of post-acute COVID symptoms: a population-based surveillance in community-dwelling users of the COVID RADAR app.急性新冠后症状的发生率、症状群和决定因素:基于 COVID RADAR 应用程序的社区居民的基于人群的监测。
BMJ Open. 2024 Sep 10;14(9):e087235. doi: 10.1136/bmjopen-2024-087235.

引用本文的文献

1
Long COVID symptoms in the COVID unit of the emergency Department of Abderrahmen Mami Hospital in Tunisia: prevalence, main symptoms, and associated factors.突尼斯阿卜杜勒拉赫曼·马米医院急诊科新冠病房的新冠长期症状:患病率、主要症状及相关因素
Pan Afr Med J. 2025 Apr 23;50:109. doi: 10.11604/pamj.2025.50.109.37221. eCollection 2025.
2
An Epidemiological Cross-sectional Study of Post-COVID-19 Syndrome in Patients of Anand District.阿南德地区新冠后综合征患者的流行病学横断面研究
Indian J Community Med. 2025 May-Jun;50(3):486-499. doi: 10.4103/ijcm.ijcm_109_23. Epub 2024 Oct 3.
3
In-hospital mortality among hospitalized COVID-19 patients in a tertiary care hospital in Dhaka City: a retrospective cohort study.

本文引用的文献

1
Long-term Health Consequences of COVID-19.新冠病毒病的长期健康后果
JAMA. 2020 Nov 3;324(17):1723-1724. doi: 10.1001/jama.2020.19719.
2
Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery.新冠康复者康复三个月后肺功能及相关生理特征的随访研究
EClinicalMedicine. 2020 Aug;25:100463. doi: 10.1016/j.eclinm.2020.100463. Epub 2020 Jul 15.
3
Management of post-acute covid-19 in primary care.初级保健中新冠后急性期的管理。
达卡市一家三级护理医院中新冠肺炎住院患者的院内死亡率:一项回顾性队列研究。
Front Med (Lausanne). 2025 May 20;12:1571865. doi: 10.3389/fmed.2025.1571865. eCollection 2025.
4
Assessment of Post-COVID-19 Functional Status and Complications Among Survivors at a Tertiary Healthcare Center in Bangladesh.孟加拉国一家三级医疗中心对新冠病毒感染康复者的新冠后功能状态及并发症评估
Cureus. 2025 Apr 23;17(4):e82866. doi: 10.7759/cureus.82866. eCollection 2025 Apr.
5
Symptoms of Depression and Anxiety After COVID-19 Despite Systematic Telemedical Care: Results From the Prospective COVID-SMART Study.尽管有系统的远程医疗护理,新冠病毒感染后抑郁和焦虑症状:前瞻性COVID-SMART研究结果
Depress Anxiety. 2025 Apr 13;2025:9989990. doi: 10.1155/da/9989990. eCollection 2025.
6
The impact of long COVID on heart rate variability: a cross-sectional study.长新冠对心率变异性的影响:一项横断面研究。
BMC Infect Dis. 2025 Feb 24;25(1):261. doi: 10.1186/s12879-024-10361-9.
7
Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome: a review of literature on COVID-19 sequelae and gut dysbiosis.新冠病毒病急性后遗症中的慢性炎症对肠道微生物群产生调节作用:关于新冠病毒病后遗症与肠道菌群失调的文献综述
Mol Med. 2025 Jan 23;31(1):22. doi: 10.1186/s10020-024-00986-6.
8
Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates.阿联酋糖尿病患者中与新冠后状况相关的风险因素
J Epidemiol Glob Health. 2025 Jan 20;15(1):6. doi: 10.1007/s44197-025-00346-5.
9
Symptom Persistence Following COVID-19 Infection among an Indigenous Community Residing in the Isthmus of Tehuantepec, Oaxaca, Mexico.墨西哥瓦哈卡州特万特佩克地峡一个原住民社区中新冠病毒感染后的症状持续情况
J Clin Med. 2024 Sep 7;13(17):5310. doi: 10.3390/jcm13175310.
10
A comparison of COVID-19 and post-COVID-19 syndrome among symptomatic and asymptomatic patients in Bangladesh: A retrospective cohort study.孟加拉国出现症状和无症状患者中新冠病毒病与新冠后综合征的比较:一项回顾性队列研究
Heliyon. 2024 Aug 15;10(16):e36202. doi: 10.1016/j.heliyon.2024.e36202. eCollection 2024 Aug 30.
BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026.
4
Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis.新型冠状病毒肺炎患者嗅觉和味觉障碍的系统评价和荟萃分析。
Mayo Clin Proc. 2020 Aug;95(8):1621-1631. doi: 10.1016/j.mayocp.2020.05.030. Epub 2020 Jun 6.
5
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.症状持续时间和多州医疗保健系统网络中 COVID-19 门诊患者恢复健康延迟的风险因素 - 美国,2020 年 3 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. doi: 10.15585/mmwr.mm6930e1.
6
Extrapulmonary complications of COVID-19: A multisystem disease?COVID-19 的肺外并发症:一种多系统疾病?
J Med Virol. 2021 Jan;93(1):323-335. doi: 10.1002/jmv.26294. Epub 2020 Jul 22.
7
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.
8
The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.24410 名新型冠状病毒(SARS-CoV-2;COVID-19)感染者的症状流行率:来自 9 个国家的 148 项研究的系统评价和荟萃分析。
PLoS One. 2020 Jun 23;15(6):e0234765. doi: 10.1371/journal.pone.0234765. eCollection 2020.
9
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.1420 例轻症至中症 2019 年冠状病毒病欧洲患者的临床和流行病学特征。
J Intern Med. 2020 Sep;288(3):335-344. doi: 10.1111/joim.13089. Epub 2020 Jun 17.
10
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.2020 年 2 月 12 日至 3 月 16 日,美国 2019 冠状病毒病(COVID-19)患者的严重结局。
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.